Abrams Bison Investments LLC Purchases Shares of 1,820,000 Acadia Healthcare Company, Inc. $ACHC

Key Points

• Abrams Bison Investments LLC has acquired a new stake in Acadia Healthcare Company, Inc., purchasing 1,820,000 shares valued at approximately $55.18 million, which represents about 6% of its total portfolio.
• Multiple hedge funds, including Citigroup Inc. and Maverick Capital Ltd., have significantly increased their stakes in Acadia Healthcare, reflecting strong institutional interest in the company.
• Analysts have upgraded Acadia Healthcare's rating, with a consensus rating of "Moderate Buy" and an average target price of $40.77.

Abrams Bison Investments LLC acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,820,000 shares of the company's stock, valued at approximately $55,182,000. Acadia Healthcare accounts for 6.0% of Abrams Bison Investments LLC's portfolio, making the stock its 7th largest holding. Abrams Bison Investments LLC owned approximately 1.98% of Acadia Healthcare at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in shares of Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after buying an additional 1,234 shares during the period. State of Wyoming purchased a new position in shares of Acadia Healthcare during the fourth quarter worth $56,000. Covestor Ltd boosted its position in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after buying an additional 812 shares during the period. Finally, Aquatic Capital Management LLC purchased a new position in shares of Acadia Healthcare during the fourth quarter worth $97,000.

Acadia Healthcare Stock Up 0.3%

NASDAQ:ACHC traded up $0.07 during midday trading on Friday, reaching $23.72. The company had a trading volume of 2,018,492 shares, compared to its average volume of 2,215,601. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of 15.71, a PEG ratio of 4.59 and a beta of 0.89. The stock's fifty day simple moving average is $22.17 and its 200-day simple moving average is $25.05. Acadia Healthcare Company, Inc. has a 12-month low of $17.13 and a 12-month high of $79.82. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. During the same period last year, the firm earned $0.91 earnings per share. Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ACHC has been the subject of several research analyst reports. Barclays lowered their price target on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Raymond James Financial restated an "outperform" rating and set a $26.00 price target (down from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Guggenheim lowered their price target on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.